RESI JPM San Francisco 2023 Investor Panelists

15 Dec

By Joey Wong, Investor Research Analyst, Hong Kong BD, LSN

RESI JPM San Francisco 2023 is fast approaching. The Life Science Nation (LSN) team has been busy putting together a program of 8 panels that provides latest insights on early-stage life science and healthcare.

We are excited to have invited a diverse lineup of panelists from different types of investment groups, including Big Pharma, corporate VCs, medtech strategics, traditional VCs, angels and family offices, to share their strategies and approaches on early-stage investment, perspectives on industry landscape, startup ecosystem and more. As a global conference, we are also delighted to have many international investors and cross-border investment groups to join and contribute to these dynamic discussions. The goal of RESI panels is to facilitate constructive conversations between investors and fundraising CEOs, and provide tactical advice on how companies can raise capital and acquire partnerships effectively. These must-see panels are great opportunities for founders and CEOs to engage with investors and kick off their fundraising journey of 2023.

Join the panelists below at RESI JPM San Francisco:


Mel Barsky
Director of Business Development
Centre for Aging + Brain Health Innovation (CABHI)

Lana Caron
Innovation Lead
Philips Ventures
Bruce Cohen
Bruce Cohen
Venture Partner
Xeraya Capital
Matt Deschner
Matt Deschner
Business Development & Licensing – Surgical Innovations
Medtronic

Gini Deshpande
Partner of Cathay Capital
Niels Emmerich
Niels Emmerich
Vice President, Global Head Search and Evaluation
AbbVie
Xi Fang
Xi Fang
Managing Partner
Button Capital
Jon Friedland
Jon Friedland
Managing Director, Ventures
Cleveland Clinic Ventures
Amit Garg
Amit Garg
Managing Partner
Tau Ventures
Lana Ghanem
Lana Ghanem
Managing Director
Hikma Ventures
Tom Gibbs
Tom Gibbs
Director
Debiopharm Innovation Fund
Gita Gupta
Gita Gupta
Partner
NextStep Ventures
Duncan Huston-Paterson
Duncan Huston-Paterson
Senior Manager, Business Development
Amgen
Kristin King
Kristin King
Member
Boston Harbor Angels
Fiona Mack
Fiona Mack
VP, Head of CoLaborator
Bayer
Nola Masterson
Nola Masterson
Managing Director
Science Futures
Andrew Meadow
Andrew Meadow
General Partner
Health Innovation Capital
Tamir Meiri
Tamir Meiri
Senior Manager, Venture Investments
Johnson & Johnson Innovation
Ole Mensching
Ole Mensching
Co-Founder and General Partner
Apollo Health Ventures
Ravi Mistry
Ravi Mistry
Angel Investor
John Parker
John Parker
Founder & Managing Director
Springhood Ventures
Armin Rump
Armin Rump
Manager, Global Business Development
Otsuka Pharmaceutical
Akhil Saklecha
Akhil Saklecha
Chief Scientific Officer, Acute Care
Danaher Corporation
Yoke Sin
Yoke Sin
Managing Partner
iGlobe Partners
Lesley Stolz
Lesley Stolz
Regional Vice President, Early Innovation Partnering
Johnson & Johnson Innovation
Sally Wang
Sally Wang
Venture Partner
Viva BioInnovator
Oscar Zhang
Oscar Zhang
Principal
Qiming Venture Partners
Lu Zhang
Lu Zhang
Managing Partner
Fusion Fund
Cheryl Zimberlin
Cheryl Zimberlin
Investment Director
M Ventures

RESI-SF-2023-Banner-1100-wide

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: